Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Vitamax ER
- Development stage
- Unknown
- Lead developer
- Raymed
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Vitamax ER (also known as Vitamax-ER) is an oral, extended-release nutritional supplement developed and marketed by Raymed. Formulated based on the Age-Related Eye Disease Study 2 (AREDS2) guidelines, it contains a combination of lutein, zeaxanthin, vitamins, and minerals. It is designed to support eye health, particularly in managing or slowing the progression of age-related macular degeneration (AMD). Vitamax ER is available over-the-counter in India.
- Brand names
- Vitamax ERVitamax-ER
- Other names
- Vitamax ER TabletsVitamax-ER Tablets
Beyond the preview
Go deeper on Vitamax ER.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vitamax ER.